Results 161 to 170 of about 37,561 (261)

Advances in Diagnosis and Treatment With Cholangiopancreatoscopy

Digestive Endoscopy, Volume 38, Issue 4, April 2026.
ABSTRACT Endoscopic retrograde cholangiopancreatography (ERCP) remains the standard for diagnosing and treating pancreatobiliary diseases. Although non‐invasive imaging modalities have significantly improved, ERCP continues to play an indispensable role in clinical practice. However, ERCP has inherent limitations. Diagnostic challenges persist in cases
Takeshi Ogura, Nga Nguyen Trong, Jayanta Samanta   +2 more
wiley   +1 more source

Moderate increase of MET in hepatocytes protects against cholestatic liver injury by promoting an effective antioxidant response

The FEBS Journal, Volume 293, Issue 8, Page 2370-2392, April 2026.
Moderate overexpression of wild‐type Met in hepatocytes (Alb‐R26Met mouse model) boosts a strong antioxidant response dependent on the glutathione system while impairing TGF‐β signaling in the liver. This leads to improved liver regeneration and protects against DDC‐induced injury, a model for cholestatic disease sharing features with primary ...
Carlos González‐Corralejo, Juan García‐Sáez, María Figueroa‐Fuentes, Annalisa Addante, Cesáreo Roncero, Nerea Lazcanoiturburu, Beatriz Pacheco, Julián Sanz, Cristina Gato, Eva Fernández‐Calderón, María de la O López, Águeda González‐Rodríguez, Almudena Porras, Flavio Maina, Isabel Fabregat, Blanca Herrera, Aránzazu Sánchez   +16 more
wiley   +1 more source

Graves' disease with autoimmune hepatitis and primary Sclerosing cholangitis: an overlap syndrome. [PDF]

Oxf Med Case Reports
Pragathi LK, Gandhi D, Tetarbe S, Chandrashekhar SR, Shah I.   +4 more
europepmc   +1 more source

Steatotic Liver Disease: A Key Related Risk Factor in the Emergence of Metabolic Syndrome‐Related Disorders

Hepatology Research, Volume 56, Issue 4, Page 436-445, April 2026.
It is speculated that the onset of obesity‐related diseases follows the sequence of obesity → SLD → MetS‐related diseases. In this study, the contribution of SLD to each MetS‐related disease was large for T2D and hypertension and SLD contributed to the onset and new onset of the disease by the 7‐year follow‐up.
Yoshihiro Kamada, Makoto Fujii, Hitoshi Nishizawa, Shiro Fukuda, Makoto Yamada, Iichiro Shimomura, Eiji Miyoshi   +6 more
wiley   +1 more source

Prognostic value of magnetic resonance imaging in pediatric-onset primary sclerosing cholangitis. [PDF]

Ther Adv Gastroenterol
Vanhanen EJ, Lehtimäki TE, Kolho KL, Tenca A.   +3 more
europepmc   +1 more source

Prognostic scores for early mortality following transjugular intrahepatic portosystemic shunt insertion: external validation in a contemporary Australian cohort

Internal Medicine Journal, Volume 56, Issue 4, Page 552-562, April 2026.
Abstract Background Mortality following transjugular intrahepatic portosystemic shunt (TIPS) placement remains a critical concern. Traditional scoring systems, such as the Model for End‐Stage Liver Disease (MELD) and MELD‐Na, as well as the newer Modified TIPS‐Score (MOTS) and Freiburg Index of Post‐TIPS Survival (FIPS), have shown potential for ...
Nirbaanjot Walia, Oliver Nilsen, Ernest Cheung, Jonathan Abdelmalak, Jessica Spurio, Monique Fernandez, Thomas Freeman, Penelope Hey, Karl Vaz, Marie Sinclair, Avik Majumdar, Adam Testro   +11 more
wiley   +1 more source

Evaluation and management of primary sclerosing cholangitis patients awaiting liver transplantation. [PDF]

JHEP Rep
Frolkis AD, Nayagam JS, Parente A, Seager M, Sadler MD, Montano-Loza AJ, Joshi D.   +6 more
europepmc   +1 more source

Prevalence and risk factors for metabolic dysfunction–associated steatotic liver disease in Sweden: Insights from the SCAPIS cohort

Journal of Internal Medicine, Volume 299, Issue 4, Page 481-501, April 2026.
Abstract Background and Aims Metabolic dysfunction–associated steatotic liver disease (MASLD) is the most common chronic liver disease globally, but its prevalence and severity remain poorly characterized in the general population. Our aim was to estimate the prevalence of MASLD and the risk of advanced fibrosis in a large Swedish general population ...
Oumarou Nabi, Jonas Spaak, Göran Bergström, Gunnar Engström, Carl Johan Östgren, Andrei Malinovschi, Joel Kullberg, Anders Blomberg, Tomas Jernberg, Daniel P. Andersson, Hannes Hagström   +10 more
wiley   +1 more source

Primary sclerosing cholangitis in children: a single-center experience and evaluation of prognostic markers. [PDF]

Transl Gastroenterol Hepatol
Vlckova E, Hradsky O, Semjonov V, Durilova M, Kazeka D, Kubat M, Lerchova T, Bronsky J, Mitrova K.   +8 more
europepmc   +1 more source

Primary sclerosing cholangitis [PDF]

Abdominal Imaging, 1997
Majoie, C.B.L.M., Huibregtse, K., Reeders, J.W.A.J.   +2 more
openaire   +4 more sources